Massachusetts has approved rules for licensed social cannabis consumption lounges, opening the door to cannabis cafes and experience driven venues. The move creates a new consumer channel that expands the industry beyond traditional retail while emphasizing safety and compliance.

Cannabis stocks jumped as investors reacted to renewed federal policy discussions around marijuana reclassification. A move away from Schedule I could ease tax and banking barriers, creating major structural changes for the industry.

A new federal law will ban most intoxicating hemp-derived THC products by imposing a 0.4 mg THC-per-container limit and prohibiting certain synthesized cannabinoids. The rule takes effect in November 2026 and could dramatically reshape the hemp-based wellness market.

Virginia’s Joint Commission has proposed a sweeping adult-use cannabis framework ahead of the state’s expected 2026 retail launch. The plan removes local opt-outs, elevates micro-businesses, and establishes clear rules for licensing, zoning, testing, and delivery.

Rumors are growing in Washington that a second Trump administration may aggressively pursue federal cannabis rescheduling. If it happens, it would reshape banking, insurance, taxes, and interstate commerce — transforming the entire cannabis industry.

Rep. Dina Titus is demanding answers from the U.S. Attorney General after a DOJ memo signaled renewed enforcement on cannabis offenses. Her letter raises major concerns for state-legal operators who need clear federal guidance to protect their businesses and plan for the future.

Rep. Nancy Mace has introduced draft legislation aimed at reversing the new federal ban on intoxicating hemp products. The proposal could offer major relief to the $28 billion hemp-THC sector, which was blindsided by the ban buried in the government-funding deal.

Texas avoided a state-level THC ban, but a new federal spending bill could outlaw most hemp-derived THC products nationwide. Industry leaders warn the move could devastate the multi-billion-dollar hemp sector and force thousands of operators to pivot or shut down.

Congress passed new legislation narrowing the federal definition of hemp, imposing strict THC limits, and banning synthetic cannabinoids. The move could reshape the $28B hemp-THC sector and force major operational changes across manufacturing, retail, and online markets.

A federal spending bill to reopen the government includes provisions to ban many hemp-derived THC products, such as Delta-8 and hemp-based gummies and beverages. The move could devastate parts of the hemp industry and signals increasing federal intervention in cannabis regulation.

Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.

Republican support for federal cannabis legalization has dropped from 55% to 40%, according to a new Gallup poll. The decline highlights growing political polarization around cannabis — and potential challenges for federal reform heading into 2026.

Lawmakers are clashing over hemp-derived THC restrictions as part of a federal funding bill, sparking a political standoff that could shape the future of hemp regulation. The outcome could redefine how hemp and cannabis are governed nationwide.

Colombian President Gustavo Petro publicly urged Donald Trump to legalize U.S. cannabis exports, signaling how international diplomacy and cannabis reform are becoming intertwined. The move underscores Colombia’s ambitions to lead global cannabis trade as the U.S. faces pressure to modernize its federal policies.

Thirty-seven state attorneys general have urged Congress to ban hemp-derived THC products, citing health and enforcement concerns. Their unified call for federal action could reshape the future of hemp regulation — and impact every operator in the space.

Pennsylvania lawmakers advanced a bill to create a Cannabis Control Board that would oversee both medical marijuana and hemp-derived products. The move emphasizes regulatory reform and consumer safety, not adult-use legalization — but it could set the stage for a more unified and professional cannabis framework.